GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $9,000 | +80.0% | 40 | 0.0% | 0.00% | +50.0% |
Q4 2020 | $5,000 | +25.0% | 40 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $4,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $4,000 | +33.3% | 40 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $3,000 | -25.0% | 40 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $4,000 | -60.0% | 40 | -55.6% | 0.00% | -60.0% |
Q3 2019 | $10,000 | -69.7% | 90 | -52.6% | 0.01% | -70.6% |
Q2 2019 | $33,000 | +3.1% | 190 | 0.0% | 0.02% | +6.2% |
Q1 2019 | $32,000 | +77.8% | 190 | 0.0% | 0.02% | +45.5% |
Q4 2018 | $18,000 | -45.5% | 190 | 0.0% | 0.01% | -35.3% |
Q3 2018 | $33,000 | +26.9% | 190 | 0.0% | 0.02% | +13.3% |
Q2 2018 | $26,000 | +62.5% | 190 | +35.7% | 0.02% | +50.0% |
Q1 2018 | $16,000 | -11.1% | 140 | 0.0% | 0.01% | -9.1% |
Q4 2017 | $18,000 | +350.0% | 140 | +250.0% | 0.01% | +266.7% |
Q3 2017 | $4,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $4,000 | -20.0% | 40 | 0.0% | 0.00% | -25.0% |
Q1 2017 | $5,000 | +25.0% | 40 | 0.0% | 0.00% | +33.3% |
Q4 2016 | $4,000 | – | 40 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |